3 Lawmakers Give Terminal Cancer Patients Early Xmas Gift

lawyersandsettlements.com — Washington, DC: Three members of Congress recently sent a letter to the House Energy and Commerce Committee calling for a hearing to examine the conflicts of interest involved in the FDA's decision to deny the approval of Provenge, a new life-extending vaccine for use with terminally ill prostate cancer patients who have no other treatment options. Dec 19, 2007 View in Crawl 4